Mylan Expands EpiPen Recall to Some Devices Distributed in U.S.

Mylan NV said it was expanding a recall of its EpiPen allergy injection to some lots of the device that have been distributed in the U.S., after defects were found that could keep the injectors from working in an emergency.

Mylcan called the defect “extremely rare,” and is recalling 13 lots of the pens. The company said it will replace pens from the recalled lots at no cost, and that people should keep the ones they have until they get their replacements.